Discovery of novel targets of quinoline drugs in the human purine binding proteome

Molecular Pharmacology

Volumn 62, Issue 6, 2002, Pages 1364-1372

  Graves, Paul R ^a   Kwiek, Jesse J ^a,c   Fadden, Patrick ^b   Ray, Rupa ^a   Hardeman, Klaas ^b   Coley, Andrew M ^d   Foley, Michael ^d   Haystead, Timothy A J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Serenex Inc   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CHLOROQUINE; DICOUMAROL; HYDROXYCHLOROQUINE; MEFLOQUINE; MEPACRINE; PRIMAQUINE; PROTEOME; QUININE; QUINOLINE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) 2; SEPHAROSE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTHRITIS; ARTICLE; CELL LYSATE; DRUG MECHANISM; ERYTHROCYTE; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS; MALARIA; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEOMICS;

ADENOSINE TRIPHOSPHATE; ALDEHYDE DEHYDROGENASE; ANIMALS; ANTIMALARIALS; CHLOROQUINE; CHROMATOGRAPHY, AGAROSE; ENZYME INHIBITORS; ERYTHROCYTES; HUMANS; ISOENZYMES; MEFLOQUINE; MICE; NAD(P)H DEHYDROGENASE (QUINONE); PLASMODIUM FALCIPARUM; PRIMAQUINE; PROTEOME; SEPHAROSE;

EID: 0036892305     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.6.1364     Document Type: Article

References (32)

1. Adelusi SA, Dawodu AH, and Salako LA (1982) Kinetics of the uptake and elimination of chloroquine in children with malaria. Br J Clin Pharmacol 14:483-487.
2. Chan AC, Chow CK, and Chiu D (1999) Interaction of antioxidants and their implication in genetic anemia. Proc Soc Exp Biol Med 222:274-282.
3. Chen S, Wu K, and Knox R (2000) Structure-function studies of DT-diaphorase (NQO1) and NRH: Quinone oxidoreductase (NQO2). Free Radical Biol Med 29: 276-284.
4. Chen S, Wu K, Zhang D, Sherman M, Knox R, and Yang CS (1999) Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: Combined approach involving site-directed mutagenesis, inhibitor-binding analysis and computer modeling. Mol Pharmacol 56:272-278.
5. Cleland WW (1979) Statistical analysis of enzyme kinetic data. Methods Enzymol 63:103-138.
6. Damer CK, Partridge J, Pearson WR and Haystead TA (1998). Rapid identification of protein phosphatase 1-binding proteins by mixed peptide sequencing and data base searching. Characterization of a novel holoenzymic form of protein phosphatase 1. J Biol Chem 273:24396-24405.
7. Dinkova-Kostova AT and Talalay P (2000) Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. Free Radical Biol Med 29:231-240.
8. Foley M and Tilley L (1997) Quinoline antimalarials: Mechanisms of action and resistance. Int J Parasitol 27:231-240.
9. Foley M and Tilley L (1998) Quinoline antimalarials: Mechanisms of action and resistance and prospects for new agents. Pharmacol Ther 79:55-87.
10. Fox RI (1993) Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin Arthritis Rheum 23(Suppl 1):82-91.
11. Green LS and Danubio ME (1997) Adaptation to Malaria. Gordon and Breach Publishers, Amsterdam.
12. Haystead CM, Gregory P, Sturgill TW, and Haystead TA (1993) γ-Phosphate-linked ATP-Sepharose for the affinity purification of protein kinases. Rapid purification to homogeneity of skeletal muscle mitogen-activated protein kinase kinase. Eur J Biochem 214:459-467.
13. Korth C, May BC, Cohen FE, and Prusiner SB (2001) Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA 98:9836-9841.
14. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. (2001) Initial sequencing and analysis of the human genome. Nature (Lond) 409:860-921.
15. Lind C, Cadenas E, Hochstein P, and Ernster L (1990) DT-diaphorase: Purification, properties and function. Methods Enzymol 186:287-301.
16. Lindquist NG (1973) Accumulation of drugs on melanin. Acta Radiol Diagn 325:1-92.
17. Long DJ 2nd and Jaiswal AK (2000) NRH:quinone oxidoreductase2 (NQO2). Chem Biol Interact 129:99-112.
18. Lopez-Shirley K, Zhang F, Gosser D, Scott M, and Meshnick SR (1994) Antimalarial quinones: Redox potential dependence of methemoglobin formation and heme release in erythrocytes. J Lab Clin Med 123:126-130.
19. Mackey AJ, Haystead TAJ, and Pearson WR (2002) Getting more from less: Algorithms for rapid protein identification with multiple short peptide sequences. Mol Cell Proteomics 1.2:139-147.
20. Martini G and Ursini MV (1996) A new lease of life for an old enzyme. Bioessays 18:631-637.
21. O'Brien PJ (1991) Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact 80:1-41.
22. Ortiz-Maldonado M, Gatti D, Ballou DP, and Massey V (1999). Structure-function correlations of the reaction of reduced nicotinamide analogues with phydroxybenzoate hydroxylase substituted with a series of 8-substituted flavins. Biochemistry 38:16636-16647.
23. Postma NS, Mommers EC, Eling WM, and Zuidema J (1996) Oxidative stress in malaria: Implications for prevention and therapy. Pharm World Sci 18:121-129.
24. Rynes RI (1997) Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol 36:799-805.
25. Savarino A, Gennero L, Chen HC, Serrano D, Malavasi F, Boelaert JR, and. Sperber K (2001) Anti-HIV effects of chloroquine: Mechanisms of inhibition and spectrum of activity. AIDS 15:2221-2229.
26. Schlichtherle M, Wahlgren M, Perlmann H, and Scherf A (2000) Methods in Malaria Research, 3rd Ed. Malaria Research and Reference Reagent Resource Center/American Type Culture Collection, Manassas, VA.
27. Shevchenko A, Wilm M, Vorm O, and Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850-858.
28. Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G, Drousiotou A, Dangerfield B, Lefranc G, Loiselet J, et al. (2001). Haplotype diversity and linkage disequilibrium at human G6PD: Recent origin of alleles that confer malarial resistance. Science (Wash DC) 293:455-462.
29. Van Beek MJ and Piette WW (2001) Antimalarials. Dermatol Clin 19:147-60.
30. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, et al. (2001) The sequence of the human genome. Science (Wash DC) 291:1304-1351.
31. White NJ (1985) Clinical pharmacokinetics of antimalarial drugs. Clin Pharmacokinet 10:187-215.
32. Zhao Q, Yang XL, Holtzclaw WD, and Talalay P (1997) Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase). Proc Natl Acad Sci USA 94:1669-1674.